ContraFect   Report issue

For profit Phase 3
Founded: New York NY United States (2008)

Organization Overview

First Clinical Trial
2015
NCT02439359
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ContraFect